RLS USA

RLS (Radioisotope Life Sciences) is the largest pure-play radiopharmaceutical pharmacy network in the United States, operating over 30 specialized facilities across the country. The company was established in 2020 through the acquisition of GE Healthcare's US radiopharmacy retail business, positioning it as a critical infrastructure provider for molecular imaging and precision medicine. RLS specializes in the preparation, compounding, and delivery of patient-specific radiopharmaceutical doses for diagnostic and therapeutic use. Beyond distribution, the company offers comprehensive contract development and manufacturing (CDMO) services to biopharmaceutical partners. Their network supports advanced clinical applications in oncology, cardiology, and neurology, maintaining high standards of USP <797> and <825> compliance.